Idacta mAb INT-001 represents an interesting clinical approach for treating selected hematologic tumors. This antibody shows a special process of effect, particularly binding to CD38, an membrane protein present often https://mayafjvv853268.wikiannouncing.com/8191965/idacta_mab_int_001_a_novel_antibody_under_progression